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This study’s objective was to determine the in vitro antimicrobial activities of galliummaltolate (GaM) and 20 other antimicro-
bial agents against clinical equine isolates of Corynebacterium pseudotuberculosis. The growth of cultured isolates was not inhib-
ited by any concentration of GaM.MIC data revealed susceptibility to commonly used antimicrobials.
This study’s objective was to evaluate the in vitro susceptibilityof Corynebacterium pseudotuberculosis to gallium and 20 con-
ventional antimicrobial agents. We hypothesized that equine iso-
lates of C. pseudotuberculosis would be susceptible to commonly
used antimicrobials and GaM.
One hundred equine isolates of C. pseudotuberculosis were ob-
tained from the Texas A&M University Veterinary Medical
Teaching Hospital (VMTH) Clinical Microbiology Laboratory
repository and from the Diagnostic Bacteriology/Mycology Sec-
tion at the Texas Veterinary Medical Diagnostic Laboratory
(TVMDL). Isolates were confirmed as C. pseudotuberculosis using
rapid identification test kits (at VMTH, RapID CB Plus system
[Remel, Lenexa, KS]; at TVMDL, API Coryne [bioMérieux, Dur-
ham, NC]). Isolates were stored at80°C in Trypticase soy broth
(BD, Franklin Lakes, NJ) supplemented with 10% glycerol.
The MIC of GaM against isolates of C. pseudotuberculosis was
evaluated by macrodilution. Isolates were transferred from frozen
stock onto brain heart infusion (BHI) (BD, Franklin Lakes, NJ)
agar plates and allowed to grow for 48 h at 37°C. One or two
isolated colonies were then selected from each plate and inocu-
lated into 5 ml of BHI broth (supplemented with 0.1% Tween 80
[Sigma-Aldrich, St. Louis, MO] to prevent clumping of the C.
pseudotuberculosis colonies and 20 g/ml 2,2=-dipyridyl [Sigma-
Aldrich, St. Louis, MO] to chelate free iron) and incubated at 37°C
for 24 h.
Following incubation, each isolate was resuspended in the BHI
broth to spectrophotometrically achieve an optical density of 0.08
to 0.10 at a wavelength of 600 nm (optically comparable to that of
a 0.5 McFarland standard). Each suspension contained approxi-
mately 3 106 CFU/ml of C. pseudotuberculosis. The suspensions
were immediately diluted in the BHI broth to achieve a working
concentration of 1 106 CFU/ml, which was combined with each
GaM dilution to achieve a final concentration of 5 105 CFU/ml.
Two-fold serial dilutions of GaM in BHI broth were made to
achieve 6 concentrations ranging from 1,024 M to 32 M. The
diluted inoculum for each isolate was added 1:1 to each concen-
tration of GaM in 12-mm by 75-mm round-bottom tubes (BD,
Franklin Lakes, NJ) for final concentrations of GaM of 512, 256,
128, 64, 32, and 16 M. Positive (inoculum only) and negative
(without inoculum) controls were prepared for each isolate or
GaM dilution. Additionally, 5 isolates were tested by the same
methods, but GaM was replaced with gentamicin (Gibco Invitro-
gen, Invitrogen Corp., Carlsbad, CA). Tubes were incubated for
24 h at 37°C on a shaker and read by visual inspection. Growth or
no growth was recorded. Measurements were considered invalid if
no growth was noted in the positive control. For each isolate, the
MIC was defined as the lowest concentration of GaM inhibiting
visible growth in the tube.
Sixty-four isolates were used for gallium susceptibility testing.
Following 24 h of incubation, the growth of C. pseudotuberculosis
was observed in all isolates at every concentration. The MIC of
gentamicin was uniformly 2 mg/liter (0.42 M). The sample size
was limited due to the consistency of results.
Standard antimicrobial MIC50s and MIC90s were determined
using commercially available veterinary susceptibility plates
(TREK Diagnostic Systems, Cleveland, OH). Plate preparation
employed a broth microdilution technique, which correlates well
with the standard broth dilution method (1).
Isolates were prepared as described in the Clinical and Labora-
tory Standards Institute (CLSI) (2) approved standard for antimi-
crobial susceptibility testing. Ten microliters of suspension was
transferred into 10 ml of cation-adjusted Mueller-Hinton broth
(CAMHB; TREK Diagnostic Systems, Cleveland, OH) for a final
bacterial concentration of 1 105 CFU/ml. Each well was inocu-
lated with 100l of CAMHB. Each plate included positive-control
(no-antimicrobial) wells. The plates were sealed and incubated in
room air at 35°C. Plates were read by visual inspection at 24 and 48
h postincubation because of the slow growth of the organism (2,
3). Results (growth/no growth) were recorded. Plates were con-
sidered invalid if there was insufficient growth in the positive con-
trol. The assay was validated weekly using Staphylococcus aureus
ATCC 29213 and Escherichia coli ATCC 25922. The MIC for each
isolate was defined as the lowest concentration of an antimicrobial
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to inhibit any visible growth. The MICs required to inhibit 50%
(MIC50) and 90% (MIC90) of isolates were determined at 24 and
48 h.
Ninety-four isolates were available for antimicrobial suscepti-
bility testing. The MICs obtained for S. aureus 29213 and E. coli
ATCC 25922 were within the reference interval proposed by the
CLSI (2). The MIC50 and MIC90 results at 24 and 48 h are sum-
marized in Table 1.
Gallium maltolate was investigated because C. pseudotubercu-
losis possesses genes for iron uptake that are activated in iron-poor
environments (4).Rhodococcus equi, a related organism, is suscep-
tible to GaM (5, 6). In the present study, GaM failed to inhibit the
growth of C. pseudotuberculosis.
Possible explanations for GaM’s lack of effect on the growth of
C. pseudotuberculosis include the potential to utilize other metals
as a metallocofactor when iron is not available. A closely related
species (Corynebacterium ammoniagenes) has been shown to uti-
lize manganese in this way (7).
Another possibility is the potential for the organism to use
siderophores to obtain iron. Related bacteria use siderophores to
obtain iron from intramacrophage ferritin. Corynebacterium
pseudotuberculosis also contains a cluster of iron acquisition genes
(8) that may have enabled the use of chelated iron.
Because C. pseudotuberculosis failed to grow in minimal media,
BHI supplemented with 20 g/ml of 2,2=-dipyridyl and 0.1%
Tween 80 was selected based on the results of Billington et al. (9).
The chelating effects of 2,2=-dipyridyl on gallium are unknown; it
is possible that the GaM was chelated, mitigating any possible
antibacterial effects.
MIC values were similar to those reported for mixed-source
isolates (10–12). Because of phenotypic differences between the
equine and ovine strains and our interest in equine medicine, only
equine isolates were evaluated (10). The antimicrobials tested
were selected because they were included on the standard com-
mercially available antimicrobial susceptibility plate. Although
most antimicrobials performed well against C. pseudotuberculosis
in vitro, in vivo activity is likely to be limited to drugs with good
lipid solubility and intracellular activity.
The MIC values after 24 and 48 h of growth showed good
agreement. For penicillin and oxacillin, the MIC90 values at 48 h
were 1 concentration higher than at 24 h. For amikacin and tri-
methoprim-sulfamethoxazole, the MIC range was greater at 48 h
than at 24 h.
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TABLE 1 Summary of MICs of 20 antimicrobial agents for equine
isolates of Corynebacterium pseudotuberculosis
Antimicrobial
24 h 48 h
Range (M)
MIC50
(M)
MIC90
(M) Range (M)
MIC50
(M)
MIC90
(M)
Amikacin All4 4 4 4 to 16 4 4
Ampicillin All0.25 0.25 0.25 All0.25 0.25 0.25
Azithromycin All0.25 0.25 0.25 All0.25 0.25 0.25
Cefazolin All4 4 4 All4 4 4
Ceftazidime 1 to 32 16 16 1 to 32 16 32
Ceftiofur 0.25 to 0.5 0.5 0.5 0.25 to 0.5 0.5 0.5
Chloramphenicol All4 4 4 All4 4 4
Clarithromycin All1 1 1 All1 1 1
Doxycycline All2 2 2 All2 2 2
Enrofloxacin All0.25 0.25 0.25 All0.25 0.25 0.25
Erythromycin All0.25 0.25 0.25 All0.25 0.25 0.25
Gentamicin 1 to 2 1 1 1 to 2 1 1
Imipenem All1 1 1 All1 1 1
Oxacillin 0.25 to4 2 2 0.25 to4 2 4
Penicillin 0.06 to 0.25 0.06 0.06 0.06 to 0.25 0.12 0.12
Rifampin All1 1 1 All1 1 1
Tetracycline All2 2 2 All2 2 2
Ticarcillin 8 to 16 8 8 8 to 16 8 8
Ticarcillin-clavulanate All8 8 8 All8 8 8
Trimethoprim-
sulfamethoxazole
All0.5 0.5 0.5 0.5 to 1 0.5 0.5
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